Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
New Tiger Group Division Monetizes Surplus Energy and Industrial Equipment for Global Energy Companies
El ensayo clínico DOORwaY90 de Sirtex Medical demuestra controlar en un 100 % los tumores locales con las microesferas SIR-Spheres®, lo que establece un nuevo referente en el tratamiento con Y-90 para el carcinoma hepatocelular
6K Additive Hosts Congressman Guy Reschenthaler to Highlight Domestic Production of Critical Refractory Metals